Matches in Nanopublications for { ?s ?p "DDI between Omeprazole and Tipranavir - Tipranavir, co-administered with Ritonavir, may decrease the plasma concentration of Omeprazole. Consider alternate therapy or increase the dose of Omeprazole based on the therapeutic response. [drugbank_resource:DB00338_DB00932]"@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- drugbank_resource:DB00338_DB00932 label "DDI between Omeprazole and Tipranavir - Tipranavir, co-administered with Ritonavir, may decrease the plasma concentration of Omeprazole. Consider alternate therapy or increase the dose of Omeprazole based on the therapeutic response. [drugbank_resource:DB00338_DB00932]" assertion.